A Look At Apple iMac With Retina 5K Display

Apple used its recent media event to announce the long-awaited arrival of the retina-display iMac. The model will be officially known as the “iMac with Retina Display.” One of the main features of the event was the news that the flagship 27-inch iMac will now feature a high-resolution, high-DPI screen, which runs at 5120×2880. The iMac is the latest in a series of Apple Inc … Continue reading A Look At Apple iMac With Retina 5K Display

Stock in News: Google Inc (NASDAQ GOOG) Misses the Mark With Q3 Report but All Is Not Lost

Google Inc (NASDAQ GOOG) is a Mountain View, California based multinational corporation that specializes in Internet-related products and services. The Internet giant has a variety of services including search engines, online advertising, cloud computing, and software. Google announced its substandard third quarter report on Thursday, October 16th, making this the fourth consecutive quarter in which the company has fallen short on earnings expectations. In its … Continue reading Stock in News: Google Inc (NASDAQ GOOG) Misses the Mark With Q3 Report but All Is Not Lost

Stock in News: Facebook (NASDAQ FB) Looking To Come Up With A Smartphone?

Facebook Inc (NASDAQ FB) may be planning a deal with Samsung to come up with a new smartphone, according to reports from The Korean Herald and The Korea Times (via 9to5Google). It seems that the social networking company has not retired its quest of launching a phone even after failing in its previous effort with HTC. Facebook is seeing potential in the smartphone business and … Continue reading Stock in News: Facebook (NASDAQ FB) Looking To Come Up With A Smartphone?

Biotech Finance News

Biotech Stock News: Alnylam Jumps on Positive Patisiran Data

Alnylam Pharmaceuticals, Inc (ALNY) revealed encouraging initial results from an ongoing phase II open-label extension study (n=27) on one of its most important pipeline candidates, patisiran (ALN-TTR02). The stock soared almost 19% following the announcement. Patisiran, one of the most advanced candidates at Alnylam, is a subcutaneously administrated ribo nucleic acid interference (RNAi) therapeutic being developed for the treatment of transthyretin (TTR)-mediated amyloidosis (ATTR) in … Continue reading Biotech Stock News: Alnylam Jumps on Positive Patisiran Data

Bitcoin News: A Look At The Campaign Launched Against BitLicense

Digital rights advocacy group the Electronic Frontier Foundation (EFF) is supporting privacy, free speech and innovation through a new email campaign opposing New York’s proposed BitLicense. The EFF has crafted a pre-written letter for supporters to sign and send to the New York Department of Financial Services (NYDFS) and its leading supervisor, Superintendent Ben Lawsky. The letter argues that premature regulation stifles innovation, and that … Continue reading Bitcoin News: A Look At The Campaign Launched Against BitLicense

Stock Update: Microsoft (NASDAQ MSFT) Looking To Break Language Barriers

Microsoft Corporation (NASDAQ MSFT) is bringing the world of Star Trek closer to reality with its mind-blowing real-time translation tool that it intends to be used through Skype. To demonstrate the new Microsoft Corporation (NASDAQ MSFT) technology, Quest spoke to a Microsoft engineer. He spoke English while the engineer who worked on translation technology at the technology giant spoke German. It was Skype that bridged … Continue reading Stock Update: Microsoft (NASDAQ MSFT) Looking To Break Language Barriers